Loading company…
Velsera provides software and data insights to support precision medicine in healthcare and life sciences.
Velsera provides software and data-backed insights for healthcare and life sciences organizations working on precision medicine. Its offerings bring together multi-omics and related insights. The company was formed in 2022 through the merger of PierianDx, Inc., Seven Bridges Genomics and UgenTec NV, which were portfolio companies of Summa Equity. Jamie Littlejohns was leading the firm as of 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in